Moreover, analysis of the Oncomine database indicated that the S1PR1 expression level was higher in breast cancer than in normal tissues (Fig. 1f), which suggests that S1PR1 could be a novel target for breast cancer treatment. This evidence concerns the gene S1PR1 and breast carcinoma.